Generalized Fixed Drug Eruptions Require Urgent Care: A Case Series

Area of Science:

• Dermatology
• Clinical Pharmacology

Background:

• Generalized fixed drug eruption (FDE) represents an uncommon yet severe adverse drug reaction.
• Generalized bullous FDE (GBFDE) is a rare subtype with significant morbidity and mortality.
• Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous reactions with high mortality rates.

Observation:

• This case series details one patient with generalized FDE and two patients with GBFDE.
• All three patients experienced resolution of their FDE following treatment with cyclosporine.
• One patient with GBFDE required intensive care unit (ICU) monitoring due to the severity of the reaction.

Findings:

• Cyclosporine demonstrated efficacy in resolving both generalized FDE and GBFDE in the observed cases.
• Early recognition and prompt management are critical for patients presenting with GBFDE.
• The mortality rate associated with GBFDE is comparable to that of SJS/TEN.

Implications:

• Cyclosporine may be a viable treatment option for severe generalized FDE and GBFDE.
• Increased awareness and rapid diagnostic capabilities for GBFDE are crucial for improving patient outcomes.
• The findings underscore the critical need for immediate medical intervention in suspected GBFDE cases to mitigate life-threatening complications.